Aurobindo Pharma

$545+ Mn Finasteride Market - Global Opportunity Analysis and Industry Forecast, 2021-2022 & 2031: Affordable Access to Generic Finasteride Fuel Market Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 13, 2023

The "Finasteride Market By Application, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Finasteride Market By Application, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
  • In addition, a rise in prevalence of benign prostatic hyperplasia (BPH) is expected to fuel the market growth.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the finasteride market analysis from 2021 to 2031 to identify the prevailing finasteride market opportunities.
  • The report includes the analysis of the regional as well as global finasteride market trends, key players, market segments, application areas, and market growth strategies.

United States Generic Drugs Market Trends and Forecast Report 2023-2028: Demand for Affordable High-Quality Drugs & Increasing Availability Fueling the Multi-Billion Industry - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 12, 2023

The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The United States Generic Drugs Market is on a robust trajectory, with a projected valuation of approximately $147.57 billion by 2028, surging from $101.77 billion in 2022.
  • California, Texas, New York, Florida, Pennsylvania, Ohio, Illinois, North Carolina, Georgia, Michigan, and other states play an instrumental role in the United States Generic Drugs Industry.
  • Increasing Availability: The ever-increasing number of generic drugs available in the market has led to a growth in commercial payments for these drugs.

North America Dominates the Global Gabapentin Market with Developed Healthcare System and High Adoption Rates - ResearchAndMarkets.com

Retrieved on: 
Monday, August 7, 2023

The global gabapentin market size is expected to reach USD 3.07 billion by 2030, expanding at a CAGR of 5.35% from 2023 to 2030.

Key Points: 
  • The global gabapentin market size is expected to reach USD 3.07 billion by 2030, expanding at a CAGR of 5.35% from 2023 to 2030.
  • The other key growth driver is the rising geriatric population which is more to epilepsy and conditions such as neuropathic pain.
  • Moreover, developed regions such as North America and Europe are further making policy changes to reduce the burden on the healthcare system by promoting the use of generics such as gabapentin.
  • North America is expected to dominate the market over the forecast period, due to a developed healthcare system that facilitates the adoption of drugs such as gabapentin.

Global HIV Treatment Market Analysis Report 2023: A $25+ Billion Market by 2030 - Focus on Combination Therapies Gaining Momentum - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 29, 2023

The "Global HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030.
  • The global HIV treatment market is projected to grow at a CAGR of 1.42% during the forecast period of 2023-2030.
  • These ongoing efforts are instrumental in shaping the future of the global HIV treatment market.

India Pharmaceutical Export Market Analysis Report 2023: Market Grew by 11.88% Between FY 2019 and FY 2022 Despite the Global Market Shrinking 1-2% - ResearchAndMarkets.com

Retrieved on: 
Friday, May 5, 2023

The "Pharmaceutical Export Market in India" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Export Market in India" report has been added to ResearchAndMarkets.com's offering.
  • The Indian Pharmaceutical exports market grew by 11.88% between FY 2019 and FY 2022 to reach INR 1,445.81 Bn in FY 2022, despite the global pharmaceutical industry shrinking by 1-2% in 2020 due to COVID-19.
  • This was despite the global industry reduced by almost 2% in 2020 on account of COVID-19.
  • The pharmaceutical industry has witnessed rapid growth in the past few decades and is expected to develop further, owing to huge export possibilities.

Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022

These infections result from parasites, which are tiny organisms that live on or inside people and animals.

Key Points: 
  • These infections result from parasites, which are tiny organisms that live on or inside people and animals.
  • There are various antiparasitic drugs, each drug targets a specific parasite.
  • Antiparasitic drugs treat several kinds of infections that result from a thousand types of parasites.
  • This would in turn increase demand for antiparasitic drugs and hence fuel growth of the global antiparasitic drugs market over the forecast period.

Vitiligo Treatment Market Research Report 2022: A $1.55 Billion Market in 2021 - Global Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 10, 2022

The "Vitiligo Treatment Market Report by Product, by Application and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vitiligo Treatment Market Report by Product, by Application and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The vitiligo treatment market size is estimated to be USD 1551.3 million in 2021 and is expected to witness a CAGR of 6.12% during the forecast period 2022-2029.
  • North America region accounted for the highest revenue in the vitiligo treatment market and is expected to maintain its dominance during the forecast period.
  • This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and application from 2021 to 2029.

Global Branded Generics Market Report 2022: Growing Potential in Emerging Markets Creates Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 21, 2022

The Global Branded Generics Market is segmented based on Product, Applications, Distribution Channel, and Geography.

Key Points: 
  • The Global Branded Generics Market is segmented based on Product, Applications, Distribution Channel, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Branded Generics Market.
  • The Global Branded Generics Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Biosimilar Monoclonal Antibodies Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 30, 2022

The "Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound" report has been added to ResearchAndMarkets.com's offering.
  • Biosimilar Monoclonal Antibodies Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar monoclonal antibodies market.
  • The biosimilar monoclonal antibodies market consists of sales of biosimilar monoclonal antibodies and related services by entities (organizations, sole traders and partnerships) that produce biosimilar monoclonal antibodies, which are used to treat patients with chronic diseases such as cancer, rheumatoid arthritis, and autoimmune disease.
  • Global Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.2.

Pharmaceutical API Manufacturing Global Market Research Report 2021: Focus on Chemical API, Biological API, Innovative Drugs, Generics, OTC - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 8, 2021

The "Pharmaceutical API Manufacturing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical API Manufacturing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the pharmaceutical active pharmaceutical ingredients (API) manufacturing market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim), Pfizer, Inc. and Aurobindo Pharma.
  • The pharmaceutical active pharmaceutical ingredients (API) manufacturing market consists of sales of pharmaceutical active pharmaceutical ingredients and related services.
  • Stringent regulations for approval of pharmaceutical drugs acts as a restraint on the pharmaceutical API manufacturing market.